CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma (Q46921510)

26 December 2017

title

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma (English)

1 reference

26 December 2017

1 reference

G Konjević

1

1 reference

26 December 2017

V Jović

2

1 reference

26 December 2017

A Vuletić

3

1 reference

26 December 2017

S Radulović

4

1 reference

26 December 2017

S Jelić

5

1 reference

26 December 2017

I Spuzić

6

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

European Journal of Clinical Investigation

published in

1 reference

26 December 2017

volume

37

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

page(s)

887-896

1 reference

26 December 2017

Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Immunology and immunotherapy of human cancer: present concepts and clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Retinoid-induced apoptosis in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The innate immune response to tumors and its role in the induction of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The role of natural killer cells in immune surveillance of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The type I interferon receptor: structure, function, and evolution of a family business.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01873.X

10.1111/J.1365-2362.2007.01873.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017